Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…
Read More

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…
Read More
Attention-Deficit/Hyperactivity Disorder (ADHD) has long been framed within the clinical literature as a pathology of deficit, characterized by an individual’s…
Read More
Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have successfully demonstrated a novel mechanism…
Read More
Solstice Oncology has successfully closed a landmark $225 million Series A funding round to accelerate the clinical development of its…
Read More
Since its inception in 1921, Science News has served as a cornerstone of independent, non-profit journalism, bridging the gap between…
Read More
The commercial explosion of generative artificial intelligence has solidified the paradigm that training foundational large language models (LLMs) requires massive,…
Read More
For decades, the global health community has faced a persistent nutritional dilemma: how to provide essential micronutrients to a growing…
Read More
In the latest installment of This Week in Virology (TWiV), episode 1286, clinical expert Dr. Daniel Griffin and co-host Vincent…
Read More
The fundamental mechanics of laboratory safety often remain invisible to the naked eye, yet the strategic management of airflow serves…
Read More
In episode 1287 of This Week in Virology (TWiV), released on January 11, 2026, the regular panel of virologists—featuring Vincent…
Read More